Literature DB >> 786689

Comparison of the antihypertensive effect of propranolol and practolol combined with chlorthalidone.

G G Geyskes, A Stutterheim, P Boer, E J Mees.   

Abstract

A double blind cross-over trial of fixed doses of propranolol (640 mg/day) and the cardioselective drug practolol (1600 mg/day) was performed in 28 patients with essential hypertension whose blood pressure was not adequately controlled by chlorthalidone (100 mg 3 times weekly) alone. Chlorthalidone alone was given during the first (control) period, and it was continued throughout the propranolol and practolol treatment periods, each of 10 weeks. The systolic and diastolic blood pressures were lowered significantly by both the beta blocking drugs. The changes in blood pressure caused by altering the patient's position were the same after both beta blockers. Propranolol produced slightly lower values than practolol, but the difference was significant only for diastolic blood pressure in the sitting and supine positions. In individual patients the final blood pressure after propranolol was correlated with the final blood pressure after practolol. Only minimal side-effects of either drug were noticed. It is concluded that the doses employed both of propranolol and practolol had a good and approximately equal antihypertensive effect when combined with chlorthalidone treatment. There was no correlation between the final blood pressure and plasma renin activity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 786689     DOI: 10.1007/bf00614001

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients.

Authors:  J Castenfors; H Johnsson; L Orö
Journal:  Acta Med Scand       Date:  1973-03

2.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

3.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.

Authors:  R C Tarazi; H P Dustan
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

4.  Physiological comparison of labile and essential hypertension.

Authors:  E D Frohlich; V J Kozul; R C Tarazi; H P Dustan
Journal:  Circ Res       Date:  1970-07       Impact factor: 17.367

5.  Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.

Authors:  L Hansson
Journal:  Acta Med Scand Suppl       Date:  1973

6.  Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).

Authors:  P Brown; H Baddeley; A E Read; J D Davies; J McGarry
Journal:  Lancet       Date:  1974-12-21       Impact factor: 79.321

7.  Accuracy of an automated ultrasound blood pressure monitor.

Authors:  H M Hochberg; H Salomon
Journal:  Curr Ther Res Clin Exp       Date:  1971-02

8.  Relationship between clinical severity of disease and hemodynamic patterns in essential hypertension.

Authors:  C T Bello; R W Sevy; C Harakal; P N Hillyer
Journal:  Am J Med Sci       Date:  1967-02       Impact factor: 2.378

9.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04

10.  Controlled trial of propranolol in hypertension.

Authors:  F J Zacharias; K J Cowen
Journal:  Br Med J       Date:  1970-02-21
View more
  1 in total

1.  Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.

Authors:  J Godbillon; A Gerardin; V A John; W Theobald
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.